Alfred Sandrock, EVP, Research & Development at BIOGEN INC. (BIIB), sold 1,500 shares at $350.00 ($525K) on 2020-11-04, disclosed to the SEC on 2020-11-06.
Open-market sale of $525k BIIB by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |